Thyroid stimulating hormone levels in cord blood are not influenced by non-thyroidal mothers' diseases
Keywords:
Congenital hypothyroidism, Screening program, Maternal diseasesAbstract
CONTEXT: Screening programs not only offer the opportunity to trace and treat almost all cases of congenital hypothyroidism but also mean large savings to the health system. However, carefully planned strategies are necessary to extend their benefits and reduce costs. OBJECTIVE: To determine the possible influence of maternal diseases that affect maternal-fetal placenta dynamics on primary thyroid stimulating hormone (TSH) screening for congenital hypothyroidism. DESIGN: Prospective non-randomized clinical trial with at least 3 months of follow-up. SETTING: A public university referral center [CAISM/Hospital das Clínicas, Faculty of Medicine, University of Campinas, Campinas, SP]. PARTICIPANTS: 415 neonates divided into 5 groups: eighty-three infants born from cardiac mothers; 98 from mothers that had toxemia; 54 of the mothers had diabetes mellitus; 40 were HIV positive and 140 had no diseases. INTERVENTION: All newborns had cord blood samples collected on filter paper at birth. MAIN MEASUREMENTS: TSH was measured from dried blood spots using a homemade immunofluorescence assay (sensitivity in dried blood spots = 0.1 mU/L). RESULTS: There was no significant difference in the mean TSH levels among the 5 groups. Moreover, TSH levels were around 5 mU/L in 48% of the newborns, indicating that our region is severely deficient in iodine. CONCLUSIONS: Our results indicate that primary TSH screening programs using cord blood are not affected by maternal diseases. We suggest that, besides its technical advantages over heel punctures with T4 primary approaches, neonatal screening using primary cord blood TSH may also be used as a monitoring tool for evaluation and control of iodine deficiency disorders (IDD).
Downloads
References
Vela M, Gamboa S, Loera-Luna A, Aguirre BE, Perez-Palacios G, Velazquez A. Neonatal screening for congenital hypothyroidism in Mexico: experience, obstacles, and strategies. J Med Screen 1999;6:77-9.
LaFranchi S. Congenital hypothyroidism: etiologies, diagnosis, and management. Thyroid 1999;9:735-40.
Kuba VM, Coeli CM, Meirelles RMR, Botler J, Faria R, Petruci CM. Avaliaçăo de custo-efetividade dos testes de rastreamento de hipotiroidismo congęnito em Campos, Rio de Janeiro. Arq Bras Endocrinol Metabol 1997;41:1-5.
Franco DB, Maciel RMB, Matsumura LK, Faria AM, Vieira JGH. Implantaçăo do programa de rastreamento do hipotiroidismo congęnito na Fundaçăo Hospitalar do Distrito Federal: metodologia, resultados, dificuldades e propostas. Estudo comparativo com recém-natos de outros estados. Arq Bras Endocrinol Metabol 1997;41:6-13.
Meirelles RMR, Maciel RMB, Machado FA, Castro AS. Subsídios para a regulamentaçăo das leis que estabelecem a obrigatoriedade do diagnóstico do hipotiroidismo congęnito e fenilcetonúria. Arq Bras Endocrinol Metabol 1991;35:12-4.
Delange F. Screening for congenital hypothyroidism used as an indicator of the degree of iodine deficiency and of its control. Thyroid 1998;8:1185-92 .
Esteves RZ. Determinaçăo da excreçăo urinária de iodo em escolares brasileiros. Săo Paulo, 1997. Universidade Federal de Săo Paulo / Escola Paulista de Medicina; 1997. Doctoral Thesis.
Medeiros-Neto G. Programa de correçăo da caręncia crônica de iodo no Brasil através da adiçăo de iodo ao sal: do sucesso inicial ŕ incerteza atual. Arq Bras Endocrinol Metabol 1998;42:235-7.
Diseases of the heart and blood vessels. Nomenclature and criteria for diagnosis. The criteria committee of the New York Heart Association. 6th edition. Boston: USA; 1964.
White P. In: Joslin's Diabetes Mellitus. 11th edition. Philadelphia: Lea & Fabiger; 1971.
Vieira JGH, Kunii IS, Nishida SK, Matsumura LK, Russo EMK, Maciel RMB. Desenvolvimento e aplicaçăo de um método imunofluorimétrico para a dosagem de tirotrofina humana (TSH) no soro e em sangue total colhido em papel de filtro. Arq Bras Endocrinol Metabol 1992;36:7-12.
Ward LS, Zanella MT, Menabó E, et al. Estimativa da relaçăo custo-benefício de um programa para detecçăo precoce do hipotiroidismo congęnito. Rev Ass Med Bras 1988;34:276-82.
Ward LS, Maciel RMB, Magalhăes RF, et al. Comparaçăo entre duas estratégias para a detecçăo precoce do hipotiroidismo congęnito. Rev Ass Med Brasil 1998;44:81-6.
La Franchi S. Thyroid function in the preterm infant. Thyroid 1999;9:71-8.
Franklin RC, Carpenter LM, O'Grady CM. Neonatal thyroid function: influence of perinatal factors. Arch Dis Child 1985;60:141-4.
Fuse Y, Wakae E, Nemoto Y, et al. Influence of perinatal factors and sampling methods on TSH and thyroid hormone levels in cord blood. Endocrinol Japon 1991;38:297-302.
Haddow JE, Palomaki GE, Williams JR et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. NEJM 1999;341:549-55.
